Ajax-Loading

Amgen Inc - Other Long Term Assets

Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Long-Term-Assets" stands at 13.22 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Amgen Inc's third quarter, the item "Other Long Term Assets" stands at 13.22 Billion USD. This represents an increase of 19.97 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.84 Billion United States Dollars compared to the value the year prior.
The 1 year change is 2.84 Billion United States Dollars.
The 3 year change is 6.88 Billion United States Dollars.
The 5 year change is 7.99 Billion United States Dollars.
The 10 year change is 11.47 Billion United States Dollars.

The Serie's long term average value is 3.70 Billion United States Dollars. It's latest available value, on 09/30/2025, is 9.52 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2012, to it's latest available value, on 09/30/2025, is +19.09 Billion.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0 Billion.

Other Long Term Assets for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Other Long Term Assets905,699,262,464.00
LogoJohnson & Johnson - Other Long Term Assets486,508,953,600.00
LogoAbbVie Inc - Other Long Term Assets399,570,305,024.00
LogoRoche Holding AG - Other Long Term Assets317,433,206,677.55
LogoAstraZeneca PLC - Other Long Term Assets280,205,508,085.11